<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: The molecular mechanisms of <z:hpo ids='HP_0001513'>obesity</z:hpo>-related <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> are incompletely understood </plain></SENT>
<SENT sid="1" pm="."><plain>Macrophages accumulate in adipose tissue of <z:mp ids='MP_0001261'>obese</z:mp> individuals </plain></SENT>
<SENT sid="2" pm="."><plain>In <z:hpo ids='HP_0001513'>obesity</z:hpo>, monocyte chemoattractant protein-1 (<z:chebi fb="17" ids="50099">MCP</z:chebi>-1), a key chemokine in the process of macrophage accumulation, is overexpressed in adipose tissue </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="17" ids="50099">MCP</z:chebi>-1 is an insulin-responsive gene that continues to respond to exogenous insulin in insulin-resistant adipocytes and mice </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="17" ids="50099">MCP</z:chebi>-1 decreases insulin-stimulated <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake into adipocytes </plain></SENT>
<SENT sid="5" pm="."><plain>The A-2518G polymorphism in the distal regulatory region of <z:chebi fb="17" ids="50099">MCP</z:chebi>-1 may regulate gene expression </plain></SENT>
<SENT sid="6" pm="."><plain>The aim of this study was to investigate the impact of this gene polymorphism on <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>METHODS: We genotyped the Ludwigshafen Risk and Cardiovascular Health (LURIC) cohort ( n=3307) </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000855'>Insulin resistance</z:hpo>, estimated by homeostasis model assessment, and Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> were diagnosed in 803 and 635 patients respectively </plain></SENT>
<SENT sid="9" pm="."><plain>RESULTS: Univariate analysis revealed that plasma <z:chebi fb="17" ids="50099">MCP</z:chebi>-1 levels were significantly and positively correlated with WHR ( p=0.011), <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> ( p=0.0097) and <z:mp ids='MP_0002055'>diabetes</z:mp> ( p&lt;0.0001) </plain></SENT>
<SENT sid="10" pm="."><plain>Presence of the <z:chebi fb="17" ids="50099">MCP</z:chebi>-1 G-2518 allele was associated with decreased plasma <z:chebi fb="17" ids="50099">MCP</z:chebi>-1 ( p=0.017), a decreased prevalence of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> (odds ratio [OR]=0.82, 95% CI: 0.70-0.97, p=0.021) and a decreased prevalence of <z:mp ids='MP_0002055'>diabetes</z:mp> (OR=0.80, 95% CI: 0.67-0.96, p=0.014) </plain></SENT>
<SENT sid="11" pm="."><plain>In multivariate analysis, the G allele retained statistical significance as a negative predictor of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> (OR=0.78, 95% CI: 0.65-0.93, p=0.0060) and <z:mp ids='MP_0002055'>diabetes</z:mp> (OR=0.80, 95% CI: 0.66-0.96, p=0.018) </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS/INTERPRETATION: In a large cohort of Caucasians, the <z:chebi fb="17" ids="50099">MCP</z:chebi>-1 G-2518 gene variant was significantly and negatively correlated with plasma <z:chebi fb="17" ids="50099">MCP</z:chebi>-1 levels and the prevalence of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="13" pm="."><plain>These results add to recent evidence supporting a role for <z:chebi fb="17" ids="50099">MCP</z:chebi>-1 in pathologies associated with <z:e sem="disease" ids="C0020459" disease_type="Disease or Syndrome" abbrv="">hyperinsulinaemia</z:e> </plain></SENT>
</text></document>